Ji-Hang Yuan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Regulatory T Cells

Dendritic Cells

Top Venues

Signal transduction and targeted therapy

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Cellular & molecular biology letters

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Yue-Fan Wang, Wen-Li Zhang, Zhi-Xuan Li, Yue Liu, Jian Tan, Hao-Zan Yin, Zhi-Chao Zhang, Xian-Jie Piao, Min-Hao Ruan, Zhi-Hui Dai, Si-Jie Wang, Chen-Yang Mu, Ji-Hang Yuan, Shu-Han Sun, Hui Liu, Fu Yang
METTL14 downregulation drives S100A4 + monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression. Signal transduction and targeted therapy 9 (1) (2024)
Yue-Fan Wang, Wen-Li Zhang, Zhi-Xuan Li, Yue Liu, Jian Tan, Hao-Zan Yin, Zhi-Chao Zhang, Xian-Jie Piao, Min-Hao Ruan, Zhi-Hui Dai, Si-Jie Wang, Chen-Yang Mu, Ji-Hang Yuan, Shu-Han Sun, Hui Liu, Fu Yang
METTL14 downregulation drives S100A4 + monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression. Signal transduction and targeted therapy 9 (1) (2024)
Yue-Fan Wang, Wen-Li Zhang, Zhi-Xuan Li, Yue Liu, Jian Tan, Hao-Zan Yin, Zhi-Chao Zhang, Xian-Jie Piao, Min-Hao Ruan, Zhi-Hui Dai, Si-Jie Wang, Chen-Yang Mu, Ji-Hang Yuan, Shu-Han Sun, Hui Liu, Fu Yang
METTL14 downregulation drives S100A4 + monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression. Signal transduction and targeted therapy 9 (1) (2024)
Yue-Fan Wang, Wen-Li Zhang, Zhi-Xuan Li, Yue Liu, Jian Tan, Hao-Zan Yin, Zhi-Chao Zhang, Xian-Jie Piao, Min-Hao Ruan, Zhi-Hui Dai, Si-Jie Wang, Chen-Yang Mu, Ji-Hang Yuan, Shu-Han Sun, Hui Liu, Fu Yang
METTL14 downregulation drives S100A4 + monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression. Signal transduction and targeted therapy 9 (1) (2024)
Tingting Zhao, Tao Ding, Zhengyu Sun, Xin Shao, Shuangxi Li, Hongtao Lu, Ji-Hang Yuan, Zhi-Yong Guo
SPHK1/S1P/S1PR pathway promotes the progression of peritoneal fibrosis by mesothelial-mesenchymal transition. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (2) (2024)
Yue-Fan Wang, Wen-Li Zhang, Zhi-Xuan Li, Yue Liu, Jian Tan, Hao-Zan Yin, Zhi-Chao Zhang, Xian-Jie Piao, Min-Hao Ruan, Zhi-Hui Dai, Si-Jie Wang, Chen-Yang Mu, Ji-Hang Yuan, Shu-Han Sun, Hui Liu, Fu Yang
METTL14 downregulation drives S100A4 + monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression. Signal transduction and targeted therapy 9 (1) (2024)
Tingting Zhao, Tao Ding, Zhengyu Sun, Xin Shao, Shuangxi Li, Hongtao Lu, Ji-Hang Yuan, Zhi-Yong Guo
SPHK1/S1P/S1PR pathway promotes the progression of peritoneal fibrosis by mesothelial-mesenchymal transition. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (2) (2024)
Tingting Zhao, Tao Ding, Zhengyu Sun, Xin Shao, Shuangxi Li, Hongtao Lu, Ji-Hang Yuan, Zhi-Yong Guo
SPHK1/S1P/S1PR pathway promotes the progression of peritoneal fibrosis by mesothelial-mesenchymal transition. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (2) (2024)
Jie Li, Xiao-Gang Liu, Rui-Liang Ge, Yu-Peng Yin, Yong-da Liu, Wan-Peng Lu, Mei Huang, Xue-Ying He, Jinghan Wang, Guoxiang Cai, Shu-Han Sun, Ji-Hang Yuan
The ligation between ERMAP, galectin-9 and dectin-2 promotes Kupffer cell phagocytosis and antitumor immunity. Nature immunology (2023)
Yun-Zhang Dai, Yong-da Liu, Jie Li, Mei-Ting Chen, Mei Huang, Fang Wang, Qing-Song Yang, Ji-Hang Yuan, Shu-Han Sun
METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m 6 A-dependent manner. Cellular & molecular biology letters 27 (1) (2022)
Jie Li, Ming-Han Li, Tian-Tian Wang, Xiao-Ning Liu, Xiao-Ting Zhu, Yun-Zhang Dai, Ke-Chao Zhai, Yong-da Liu, Jia-Li Lin, Rui-Liang Ge, Shu-Han Sun, Fang Wang, Ji-Hang Yuan
SLC38A4 functions as a tumour suppressor in hepatocellular carcinoma through modulating Wnt/β-catenin/MYC/HMGCS2 axis. British journal of cancer 125 (6) (2021)